Science and Enterprise

Month: January 2012

  • Aspirin Could Help Prevent Cervical Cancer in Women with HIV

    Research by global health investigators and cancer specialists suggests that aspirin should be evaluated for its ability to prevent development of cervical cancer in HIV-infected women. The findings by a team from New York-Presbyterian Hospital and Weill Cornell Medical Center in New York, with colleagues from Qatar and Haiti, are published in the current issue…

  • Consortium Develops Virtual Mouse for Lab Testing

    Simcyp Ltd. in Sheffield, U.K., a consortium of pharmaceutical and biotech companies and research universities, has created a virtual lab mouse for use in cancer and toxicological research. Simcyp is a spin-off enterprise from Sheffield University that develops modeling and simulation tools for lab testing. Lab mice are used frequently in the development of new drugs…

  • Benefits Found for Telemedicine in Diagnosis, Disease Mgmt

    Dermatologists in the University of California at Davis Health System that use videoconferencing technology, have found live interactive consultations can improve clinical outcomes for patients from beneficial changes in medical diagnosis and disease management that otherwise might not occur. Their findings appear in the current issue of the journal Archives of Dermatology (paid subscription required).…

  • Report: Asia Closing Gap in U.S. R&D Leadership

    National Science Foundation’s new report on global research and development (R&D) trends, Science and Engineering Indicators 2012, shows in the last decade, U.S. leadership in research and development has come under severe challenge from China and other countries in Asia. The report from NSF’s policy-making body, the National Science Board, shows between 1999 and 2009,…

  • Compound That Repairs RNA Defects Identified

    Researchers at Scripps Research Institute in Jupiter, Florida have identified a compound that can help repair defects in ribonucleic acid (RNA), a genetic material similar to DNA used in protein synthesis. The team’s findings appear online in the journal ACS Chemical Biology (paid subscription required). The researchers, led by Scripps chemistry professor Matthew Disney (pictured…

  • Headphone-Wearing Pedestrian Injuries Triple Since 2004

    New research from the University of Maryland Medical Center in Baltimore shows that serious injuries to pedestrians listening to headphones have tripled in the past six years. The team led by pediatrics professor Richard Lichenstein published its findings online in the journal Injury Prevention (paid subscription required). Lichenstein and his colleagues extracted cases involving headphone…

  • NIH Funds Study of Chemical Effects on Adult Stem Cells

    Bioengineers at Rensselaer Polytechnic Institute in Troy, New York and University of California at Berkeley, have been awarded a grant from  National Institutes of Health (NIH) to study how chemicals in drugs and the environment affect human stem cells. The four-year grant of more than $2 million will fund teams led by Rensselaer’s chemical and…

  • University, Company Partner to Combat Counterfeit Chips

    The College of Nanoscale Science and Engineering (CNSE) of the University at Albany and Applied DNA Sciences Inc. in Stony Brook, New York will collaborate on nanotechnology-based solutions to prevent counterfeiting of computer chips. The partnership will focus on new methods for depositing DNA on nanoelectronics wafers and computer chips for authentication. This collaboration in…

  • Biofuels Developer Secures $17M Investment Round

    SG Biofuels Inc., a bioenergy crop company in San Diego, has completed a $17 million financing round to expand its R&D and commercialization programs. The series B funding — the second round of financing after start-up — was lead by life sciences venture capital company Thomas, McNerney & Partners, with participation from Finistere Ventures and…

  • BASF to Move Plant Biotech Work to U.S. from Germany

    The German chemical company BASF says it will move much of its plant science R&D work to the U.S. to take advantage of a more favorable regulatory climate than in Europe. The company expects to relocate its facilities in Limburgerhof, Germany and elsewhere in Europe to a new site in Research Triangle Park near Raleigh,…